Sep 13, 2021 / 06:00PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Hello, everyone. Thanks for joining us on day 3 of our Healthcare Conference. I'm Tejas Savant, and I cover the Life Science Tools and Diagnostics sector at Morgan Stanley. I'm delighted to have Illumina join us this afternoon, and representing the company is Francis deSouza, CEO, so welcome Francis.
Before we begin, just some important disclosures. Please see the research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep. And I believe, Francis, you have a safe harbor to read as well.
Francis A. deSouza - Illumina, Inc. - CEO & Director
Yes. So first, thank you so much for having me. I really appreciate the opportunity to be here. Let's start with the safe harbor statement. I've been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our
Illumina Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers